JPMorgan Funds - Global Healthcare Fund I2 (acc) - EUR

Register to Unlock Ratings
Performance History31/10/2024
Growth of 1,000 (GBP) Advanced Graph
JPMorgan Funds - Global Healthcare Fund I2 (acc) - EUR
Fund----5.8
+/-Cat----2.0
+/-B’mrk-----1.6
 
Key Stats
NAV
21/11/2024
 EUR 107.33
Day Change 0.28%
Morningstar Category™ Sector Equity Healthcare
ISIN LU2610165917
Fund Size (Mil)
21/11/2024
 USD 3977.30
Share Class Size (Mil)
21/11/2024
 EUR 19.08
Max Initial Charge -
Ongoing Charge
18/07/2024
  0.76%
Investment Objective: JPMorgan Funds - Global Healthcare Fund I2 (acc) - EUR
To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally.
Returns
Trailing Returns (GBP)21/11/2024
YTD2.75
3 Years Annualised-
5 Years Annualised-
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
Dominic Valder
05/10/2022
Bartjan van Hulten
28/02/2024
Inception Date
20/04/2023
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
MSCI World/Health Care NR USDMorningstar Gbl Health TME NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  JPMorgan Funds - Global Healthcare Fund I2 (acc) - EUR31/10/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock97.950.0097.95
Bond0.000.000.00
Property0.000.000.00
Cash1.800.351.45
Other0.600.000.60
Top 5 Regions%
United States79.79
Europe - ex Euro10.88
United Kingdom4.02
Eurozone2.97
Japan2.34
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Eli Lilly and CoHealthcareHealthcare8.86
UnitedHealth Group IncHealthcareHealthcare8.04
AbbVie IncHealthcareHealthcare6.26
Novo Nordisk AS Class BHealthcareHealthcare5.78
Thermo Fisher Scientific IncHealthcareHealthcare4.41
JPMorgan Funds - Global Healthcare Fund I2 (acc) - EUR

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures